Report Detail
Global Subcutaneous Immunoglobulins Market Insights, Forecast to 2025
- RnM2883453 |
- 19 March, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
The classification of subcutaneous immunoglobulins includes 10% purity and 20% purity, and in U.S. the proportion of 10% purity in 2016 is about 70%, and the proportion is in decreasing trend from 2012 to 2016.
Market competition is intense. In United States, only Shire (Baxalta), Grifols, CSL products got the approval of FDA. They are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Subcutaneous Immunoglobulins market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Subcutaneous Immunoglobulins market based on company, product type, end user and key regions.
This report studies the global market size of Subcutaneous Immunoglobulins in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Subcutaneous Immunoglobulins in these regions.
This research report categorizes the global Subcutaneous Immunoglobulins market by top players/brands, region, type and end user. This report also studies the global Subcutaneous Immunoglobulins market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Shire (Baxalta)
Grifols
CSL
Market size by Product
10% Purity
20% Purity
Market size by End User
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Subcutaneous Immunoglobulins market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Subcutaneous Immunoglobulins market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Subcutaneous Immunoglobulins companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Subcutaneous Immunoglobulins submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Subcutaneous Immunoglobulins are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Bottle). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Subcutaneous Immunoglobulins market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Subcutaneous Immunoglobulins Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Subcutaneous Immunoglobulins Market Size Growth Rate by Product
- 1.4.2 10% Purity
- 1.4.3 20% Purity
- 1.5 Market by End User
- 1.5.1 Global Subcutaneous Immunoglobulins Market Size Growth Rate by End User
- 1.5.2 Primary Immunodeficiency
- 1.5.3 Secondary Immunodeficiency
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Subcutaneous Immunoglobulins Market Size
- 2.1.1 Global Subcutaneous Immunoglobulins Revenue 2014-2025
- 2.1.2 Global Subcutaneous Immunoglobulins Sales 2014-2025
- 2.2 Subcutaneous Immunoglobulins Growth Rate by Regions
- 2.2.1 Global Subcutaneous Immunoglobulins Sales by Regions
- 2.2.2 Global Subcutaneous Immunoglobulins Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Subcutaneous Immunoglobulins Sales by Manufacturers
- 3.1.1 Subcutaneous Immunoglobulins Sales by Manufacturers
- 3.1.2 Subcutaneous Immunoglobulins Sales Market Share by Manufacturers
- 3.1.3 Global Subcutaneous Immunoglobulins Market Concentration Ratio (CR5 and HHI)
- 3.2 Subcutaneous Immunoglobulins Revenue by Manufacturers
- 3.2.1 Subcutaneous Immunoglobulins Revenue by Manufacturers (2014-2019)
- 3.2.2 Subcutaneous Immunoglobulins Revenue Share by Manufacturers (2014-2019)
- 3.3 Subcutaneous Immunoglobulins Price by Manufacturers
- 3.4 Subcutaneous Immunoglobulins Manufacturing Base Distribution, Product Types
- 3.4.1 Subcutaneous Immunoglobulins Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Subcutaneous Immunoglobulins Product Type
- 3.4.3 Date of International Manufacturers Enter into Subcutaneous Immunoglobulins Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Subcutaneous Immunoglobulins Sales by Product
- 4.2 Global Subcutaneous Immunoglobulins Revenue by Product
- 4.3 Subcutaneous Immunoglobulins Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Subcutaneous Immunoglobulins Breakdown Data by End User
6 North America
- 6.1 North America Subcutaneous Immunoglobulins by Countries
- 6.1.1 North America Subcutaneous Immunoglobulins Sales by Countries
- 6.1.2 North America Subcutaneous Immunoglobulins Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Subcutaneous Immunoglobulins by Product
- 6.3 North America Subcutaneous Immunoglobulins by End User
7 Europe
- 7.1 Europe Subcutaneous Immunoglobulins by Countries
- 7.1.1 Europe Subcutaneous Immunoglobulins Sales by Countries
- 7.1.2 Europe Subcutaneous Immunoglobulins Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Subcutaneous Immunoglobulins by Product
- 7.3 Europe Subcutaneous Immunoglobulins by End User
8 Asia Pacific
- 8.1 Asia Pacific Subcutaneous Immunoglobulins by Countries
- 8.1.1 Asia Pacific Subcutaneous Immunoglobulins Sales by Countries
- 8.1.2 Asia Pacific Subcutaneous Immunoglobulins Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Subcutaneous Immunoglobulins by Product
- 8.3 Asia Pacific Subcutaneous Immunoglobulins by End User
9 Central & South America
- 9.1 Central & South America Subcutaneous Immunoglobulins by Countries
- 9.1.1 Central & South America Subcutaneous Immunoglobulins Sales by Countries
- 9.1.2 Central & South America Subcutaneous Immunoglobulins Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Subcutaneous Immunoglobulins by Product
- 9.3 Central & South America Subcutaneous Immunoglobulins by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Subcutaneous Immunoglobulins by Countries
- 10.1.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Countries
- 10.1.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Subcutaneous Immunoglobulins by Product
- 10.3 Middle East and Africa Subcutaneous Immunoglobulins by End User
11 Company Profiles
- 11.1 Shire (Baxalta)
- 11.1.1 Shire (Baxalta) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Products Offered
- 11.1.5 Shire (Baxalta) Recent Development
- 11.2 Grifols
- 11.2.1 Grifols Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Grifols Subcutaneous Immunoglobulins Products Offered
- 11.2.5 Grifols Recent Development
- 11.3 CSL
- 11.3.1 CSL Company Details
- 11.3.2 Company Business Overview
- 11.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 CSL Subcutaneous Immunoglobulins Products Offered
- 11.3.5 CSL Recent Development
12 Future Forecast
- 12.1 Subcutaneous Immunoglobulins Market Forecast by Regions
- 12.1.1 Global Subcutaneous Immunoglobulins Sales Forecast by Regions 2019-2025
- 12.1.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Regions 2019-2025
- 12.2 Subcutaneous Immunoglobulins Market Forecast by Product
- 12.2.1 Global Subcutaneous Immunoglobulins Sales Forecast by Product 2019-2025
- 12.2.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Product 2019-2025
- 12.3 Subcutaneous Immunoglobulins Market Forecast by End User
- 12.4 North America Subcutaneous Immunoglobulins Forecast
- 12.5 Europe Subcutaneous Immunoglobulins Forecast
- 12.6 Asia Pacific Subcutaneous Immunoglobulins Forecast
- 12.7 Central & South America Subcutaneous Immunoglobulins Forecast
- 12.8 Middle East and Africa Subcutaneous Immunoglobulins Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Subcutaneous Immunoglobulins Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Subcutaneous Immunoglobulins . Industry analysis & Market Report on Subcutaneous Immunoglobulins is a syndicated market report, published as Global Subcutaneous Immunoglobulins Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Subcutaneous Immunoglobulins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
